Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects

Previous studies demonstrated that Bailcalin (BAI) prevented cardiac injuries under different disease models. Whether BAI protected against type 2 diabetes mellitus- (T2DM-) associated cardiomyopathy was investigated in this study. T2DM was established by the combination of streptozotocin injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ran, Liu, Yuan, Shan, Ying-guang, Gao, Lu, Wang, Fang, Qiu, Chun-guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636513/
https://www.ncbi.nlm.nih.gov/pubmed/31354905
http://dx.doi.org/10.1155/2019/3206542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636513/
https://www.ncbi.nlm.nih.gov/pubmed/31354905
http://dx.doi.org/10.1155/2019/3206542

Ejemplares similares